Abstract
Management of infection with human immunodeficiency virus (HIV) dramatically improved during the 1990s. The advent of high-performance quantitative HIV assays and highly active anti-retroviral therapy (HAART) were the two most important developments in HIV medicine. As a result, HIV mortality and morbidity have significantly reduced. This improvement in life quality and expectancy through the use of HAART has led to an increase in the number of HIV-infected patients wishing to have children. The mother-to-child transmission which was of major concern previously can now be significantly reduced by newer management strategies. This review stresses on the management of pregnancy in HIV.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Working Group on Mother-To-Child Transmission of HIV (1995) Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 8:506–510
Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK et al (1999) Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 341:394–402
Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, Whitehouse J et al (1999) Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 341:385–393
Kourtis AP, Bulterys M, Nesheim SR, Lee FK (2001) Understanding the timing of HIV transmission from mother to infant. JAMA 285:709–712
Mandelbrot L, Jasseron C, Ekoukou D, Batallan A, Bongain A, Pannier E et al (2009) Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort. Am J Obstet Gynecol 200:160e1–160e9
Cavert W, Notermans DW, Stakus K et al (1997) Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276:960–964
Zhang L, Ramratnam B, Tenner-Racz K et al (1999) Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 340:1605–1613
Fakoya A, Lamba H, Mackie N, Nandwani R, Brown A, Bernard EJ, Gilling-Smith C, Lacey C, Sherr L, Claydon P, Wallage S, Gazzard B (2008) British HIV association. BASSH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV-infection 2008. HIV Med 9:681–720
Little SJ, Holte S, Routy JP et al (2002) Antiretroviral drug resistance among patients recently infected with HIV. N Engl J Med 347(6):385–394
Richman DD, Morton SC, Wrin T et al (2004) The prevalence of antiretroviral drug resistance in the United States. AIDS 18(10):1393–1401
Lyall EG, Blott M, de Ruiter A, Hawkins D, Mercy D, Mitchla Z et al (2001) Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med 2:314–334
Boer K, Nellen JF, Patel D, Timmermans S, Tempelman C, Wibaut M, Sluman MA, van der Ende ME, Godfried MH (2007) The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG 114(2):148–155
Fiore S, Newell ML, Thorne C et al (2004) Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS 18(6):933–938
Semprini AE, Castagna C, Ravizza M et al (1995) The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 9(8):913–917
Fiore S (1999) Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. The European Mode of Delivery Collaboration. Lancet 353(9158):1035–1039
Kind C, Rudin C, Siegrist CA et al (1998) Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis. AIDS 12(2):205–210
Semprini AE, Fiore S (2004) HIV and reproduction. Curr Opin Obstet Gynecol 16:257–262
Gilling-Smith C (2001) Assisted reproduction in HIV discordant couples. AIDS Reader 10:581–587
Ohl J, Partisani M, Wittemer C et al (2003) Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience. Hum Reprod 18:1244–1249
Connor EM, Sperling RS, Gelber R et al (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331(18):1173–1180
Semprini AE, Castagna C, Ravizza M, Fiore S, Savasi V, Muggiasca ML et al (1995) The incidence of complications after caesarean section in 156 HIV positive women. AIDS 9:913–917
Sauer MV, Chang PL (2002) Establishing a clinical program to assist HIV-1 seropositive men to have children using IVF-ICSI. Am J Obstet Gynaecol 186:627–633
Gilling-Smith C (2006) Fertility management of HIV couples. Curr Obstet Gynaecol 16:299–305
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reshi, P., Lone, I.M. Human immunodeficiency virus and pregnancy. Arch Gynecol Obstet 281, 781–792 (2010). https://doi.org/10.1007/s00404-009-1334-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-009-1334-3